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Background
A randomized, double-blind, placebo-controlled study
was performed to evaluate the safety and efficacy of con-
suming an oral hyperimmune egg (HIE) protein supple-
ment during a sample training program in healthy young
adults.
Methods
Twenty-four recreationally active males (23.6 yrs, 176 cm,
69.2 kg and 17.1% body fat) were randomly assigned to
either HIE (n = 12) or an egg protein placebo (PLA) group.
Participants were supplemented with 4.5 g·d-1 for 2 d, 9
g·d-1 for 2 d and 13.5 g·d-1 for 6 d. HIE and PLA supple-
ments were identical in appearance and taste before and
after mixing with 237 mL of milk. Subjects recorded dura-
tion and severity of adverse events in a daily log.
Results
HIE and PLA had a 100% compliance with the study pro-
tocol. 17% (n = 2) of HIE and 25% (n = 3) of PLA reported
experiencing at least one adverse event. HIE reported
experiencing adverse events for a total of 10 d as com-
pared to 24 d for PLA. In HIE one subject reported experi-
encing stomach ache and diarrhea for 3 d (severity of 2 on
a 10 pt scale) and another subject reported a skin rash last-
ing 4 d (severity of 6 on a 10 pt scale). In PLA one subject
reported experiencing stomach ache and vomiting for 3 d
and increased thirst and feeling tired/sleepy for 3 d (sever-
ity of 7 and 8, respectively, on a 10 pt scale). Subjects
reported a runny nose (n = 3) lasting 1–3 days (1–5 sever-
ity on a 10 pt scale) and a cough (n = 2) lasting 3 d (sever-
ity 1–5 on a 10 pt scale).
Conclusion
It was concluded that HIE ingestion was associated with
fewer adverse events of similar or lesser severity than PLA.
All adverse events experienced by the subjects were mini-
mal and transitory in nature with none requiring medical
intervention.
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